Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral Solution
- Published
- 6 May 2026
- Units affected
- 4 single dose 75 ml bottles
- Agency
- FDA
- Country
- United States
The hazard
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0282-59.
- Brand / company
- Hikma Pharmaceuticals USA INC
- Codes / lots
- Lot # AC2040A, Exp Date: 04/2026
- Distribution
- US Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 6 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.